Loading...
Loading...
India's vaccine imports from CHINA total $20.7M across 118 shipments from 15 foreign suppliers. CHANGCHUN BCHT BIOTECHNOLOGY CO leads with $8.0M in import value; the top 5 suppliers together control 78.6% of this origin. Leading Indian buyers include NOVO MEDI SCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine โ a diversified sourcing base with multiple active suppliers from CHINA.

CHANGCHUN BCHT BIOTECHNOLOGY CO is the leading Vaccine supplier from CHINA to India, with import value of $8.0M across 48 shipments. The top 5 suppliers โ CHANGCHUN BCHT BIOTECHNOLOGY CO, SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO., LTD., SINOVAC BIOTECH CO., LTD, SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO., LTD, SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO LTD โ collectively account for 78.6% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CHANGCHUN BCHT BIOTECHNOLOGY CO | $8.0M | 48 | 38.5% |
| 2 | SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO., LTD. | $4.1M | 14 | 19.8% |
| 3 | SINOVAC BIOTECH CO., LTD | $1.8M | 11 | 8.8% |
| 4 | SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO., LTD | $1.2M | 2 | 5.9% |
| 5 | SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO LTD | $1.1M | 3 | 5.5% |
| 6 | SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO. LIMITED | $1.1M | 4 | 5.2% |
| 7 | YUXI WALVAX BIOTECHNOLOGY CO LTD | $980.3K | 3 | 4.7% |
| 8 | YUXI WALVAX BIOTECHNOLOGY CO., LTD. | $888.5K | 9 | 4.3% |
| 9 | LIAONING CHENG DA BIOTECHNOLOGY | $739.2K | 4 | 3.6% |
| 10 | LIAONING CHENG DA BIOTECHNOLOGY CO.LTD | $321.5K | 2 | 1.5% |
| 11 | M/S. SINOVAC BIOTECH CO., LTD | $240.0K | 5 | 1.2% |
| 12 | LIAONING CHENG DA BIOTECHNOLOGY CO., LTD. | $178.8K | 1 | 0.9% |
| 13 | SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO LIMITED | $4.7K | 1 | 0.0% |
| 14 | BEIJING MINHAI BIOTECHNOLOGY CO LTD | $2.1K | 1 | 0.0% |
| 15 | CANSINO BIOLOGICS INC. | $1.8K | 8 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVO MEDI SCIENCES PRIVATE LIMITED | $8.0M | 49 | 38.5% |
| 2 | DR.REDDY'S LABORATORIES LTD | $5.3M | 17 | 25.7% |
| 3 | TECHINVENTION LIFECARE PRIVATE LIMITED | $2.1M | 16 | 10.0% |
| 4 | DR REDDYS LABORATORIES LIMITED | $1.2M | 4 | 5.5% |
| 5 | DR.REDDY'S LABORATORIES LIMITED | $1.1M | 4 | 5.2% |
| 6 | G C CHEMIE PHARMIE LIMITED | $979.2K | 2 | 4.7% |
| 7 | G.C. CHEMIE PHARMIE LIMITED | $890.6K | 11 | 4.3% |
| 8 | PROSPER CHANNEL LIFESCIENCE INDIA PRIVATE LIMITED | $881.9K | 5 | 4.3% |
| 9 | PROSPER CHANNEL LIFE SCIENCE INDIA PRIVATE LIMITED | $212.6K | 1 | 1.0% |
| 10 | PROSPER CHANNEL LIFE SCIENCE INDIA PVT LTD | $145.0K | 1 | 0.7% |
| 11 | BHARAT BIOTECH INTERNATIONAL LIMITED | $1.1K | 4 | 0.0% |
| 12 | PANACEA BIOTEC LIMITED | $764 | 4 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Vaccine suppliers from CHINA to India include CHANGCHUN BCHT BIOTECHNOLOGY CO, SHENZHEN MELLOW HOPE PHARM INDUSTRIAL CO., LTD., SINOVAC BIOTECH CO., LTD. The leading supplier is CHANGCHUN BCHT BIOTECHNOLOGY CO with import value of $8.0M USD across 48 shipments. India imported Vaccine worth $20.7M USD from CHINA in total across 118 shipments.
India imported Vaccine worth $20.7M USD from CHINA across 118 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Vaccine sourced from CHINA include NOVO MEDI SCIENCES PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, TECHINVENTION LIFECARE PRIVATE LIMITED. The largest buyer is NOVO MEDI SCIENCES PRIVATE LIMITED with $8.0M in imports across 49 shipments.
The total value of Vaccine imports from CHINA to India is $20.7M USD, across 118 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
118 Verified Shipments
15 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists